Start a New Search
SHOWING 199 RESULTS
We strongly believe that financial transparency of federal award funds is essential to insuring public trust.
Reducing Regulatory Burden | Research Administration & Regulation | LettersYour new bill focuses on improving data standards and reporting, as well as streamlining financial reporting.
Reducing Regulatory Burden | Research Administration & Regulation | LettersThe nation's top research universities and AAMC issued a set of shared guidelines intended to protect the public interest when universities grant licenses for the rights to their latest scientific advances to private parties.
Intellectual Property | Technology Transfer | Research Administration & Regulation | Stanford University | Press ReleasesThose concerns have centered on the imposition of redundant and costly reporting requirements. The revised bill would eliminate explicitly duplicative reporting within three years.
Research Administration & Regulation | Reducing Regulatory Burden | LettersAAU and COGR respond to the May 24, 2013 Federal Register Notice (78 FR 31431) on the changes proposed by the U.S. Department of Commerce’s BIS with regard to the transfer of spacecraft systems and related items from the USML to the CCL (RIN 0694-AF87).
Science & Security | Export Controls | CommentsAAU and COGR respond to the May 24, 2013 Federal Register Notice (78 FR 31444) on proposed revisions to the International Traffic in Arms Regulations (ITAR) relating to U.S. Munitions List Category XV and Defense Services (RIN 1400-AD33).
Science & Security | Export Controls | CommentsA AAU-COGR task force report "Restrictions on Research Awards: Troublesome Clauses"
Science & Security | Export Controls | ReportsAAU, APLU, COGR letter on proposed changes to NIH guidelines for human stem cell research and consideration of certain human-animal chimera research.
Research Administration & Regulation | National Institutes of Health | LettersRe: Retrospective Review: Identifying and Reducing Regulatory Burdens; 81 FR 4213
Research Administration & Regulation | Reducing Regulatory Burden | LettersIn the US, ketamine is currently a Schedule III drug under the Controlled Substances Act, and strict regulations and safeguards are already in place to prevent its illegal use.
Research Administration & Regulation | Reducing Regulatory Burden | Higher Education Regulation | Letters